1. Kawai K, Fujibayashi Y, Saji H, Yonekura Y, Konishi J, Kubodera A, et al. A strategy for study of cerebral amino acid transport using iodine-123-labeled amino acid radio- pharmaceutical: 3-iodo-alpha-methyl-L-tyrosine.J Nucl Med 1991; 32: 819–824.
2. Kawai K, Fujibayashi Y, Yonekura Y, Konishi J, Saji H, Kubodera A, et al. An artificial amino acid radiopharmaceu- tical for single photon emission computed tomographic study of pancreatic amino acid transports ’123I-3-iodo-alpha-methyl-L-tyrosine.Ann Nucl Med 1992; 6: 169–175.
3. Kawai K, Fujibayashi Y, Yonekura Y, Tanaka K, Saji H, Konishi J, et al. Canine SPECT studies for cerebral amino acid transport by means of125I-3-iodo-α-methyl-L-tyrosine and preliminary kinetic analysis.Ann Nucl Med 1995; 9: 47–50.
4. Biersack HJ, Coenen HH, Stoecklin G, Reichmann K, Bockische A, et al. Imaging of brain tumors with l-3-[I-123]iodo-α-methyl tyrosine and SPECT.J Nucl Med 1989; 30: 110–112.
5. Kuwert T, Woesler B, Morgenroth C, Lerch H, Schafers M, Palkovic S, et al. Diagnosis of recurrent glioma with SPECT and iodine- 123-or-methyl tyrosine.J Nucl Med 1998; 39: 23–27.